GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OTCPK:CAMRF) » Definitions » Momentum Rank

CAMRF (Camurus AB) Momentum Rank : 10 (As of Apr. 23, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Camurus AB Momentum Rank?

Camurus AB has the Momentum Rank of 10.

Momentum Rank measures the strength and persistence of a stock's price movement over time, rated on a scale of 1 to 10.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

A higher score reflects strong price momentum and indicates greater potential for superior performance. Conversely, a lower score indicates that momentum is either too high or too low, and stocks tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison of Camurus AB's Momentum Rank

For the Biotechnology subindustry, Camurus AB's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Momentum Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Camurus AB's Momentum Rank falls into.


;
;

Camurus AB Momentum Rank Related Terms

Thank you for viewing the detailed overview of Camurus AB's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

From GuruFocus

Q3 2019 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q4 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q1 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q3 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q4 2024 Camurus AB Earnings Call Transcript

By GuruFocus News 02-14-2025

Q3 2024 Camurus AB Earnings Call Transcript

By GuruFocus News 11-09-2024

Q4 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 02-28-2024

Q1 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q1 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024